Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CDC42EP5/BORG3 modulates SEPT9 to promote actomyosin function, migration, and invasion

  • Farrugia, Aaron J.
  • Rodríguez, Javier M.
  • Orgaz, José L.
  • Lucas, María
  • Sanz-Moreno, Victoria
  • Calvo, Fernando
© 2020 Farrugia et al., Fast amoeboid migration is critical for developmental processes and can be hijacked by cancer cells to enhance metastatic dissemination. This migratory behavior is tightly controlled by high levels of actomyosin contractility, but how it is coupled to other cytoskeletal components is poorly understood. Septins are increasingly recognized as novel cytoskeletal components, but details on their regulation and contribution to migration are lacking. Here, we show that the septin regulator Cdc42EP5 is consistently required for amoeboid melanoma cells to invade and migrate into collagen-rich matrices and locally invade and disseminate in vivo. Cdc42EP5 associates with actin structures, leading to increased actomyosin contractility and amoeboid migration. Cdc42EP5 affects these functions through SEPT9-dependent F-actin cross-linking, which enables the generation of F-actin bundles required for the sustained stabilization of highly contractile actomyosin structures. This study provides evidence that Cdc42EP5 is a regulator of cancer cell motility that coordinates actin and septin networks and describes a unique role for SEPT9 in melanoma invasion and metastasis., This work was funded by the Institute of Cancer Research (A.J. Farrugia, J. Rodr´ıguez, and F. Calvo). F. Calvo is also funded by the Ramon y Cajal Research Program (RYC-2016-20352; Formación Sanitaria Especializada, Agencia Estatal de Investigación Agencia Estatal de Investigación), Fondo Europeo de Desarrollo Regional (RTI2018-096778-A-I00), and Cancer Research UK (C57744/A22057). J.L. Orgaz and V. Sanz-Moreno were supported by grants from Cancer Research UK (C33043/ A12065 and C33043/A24478), the Harry J. Lloyd Charitable Trust, and Barts Charity. M. Lucas was supported by Formación Sanitaria Especializada, Agencia Estatal de Investigación, (RYC2016-20342) and Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación, Fondo Europeo de Desarrollo Regional (RTI2018-097801-B-I00).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A mouse SWATH-mass spectrometry reference spectral library enables deconvolution of species-specific proteomic alterations in human tumour xenografts

  • Krasny, Lukas
  • Bland, Philip
  • Burns, Jessica
  • Carvalho Lima, Nadia
  • Harrison, Peter T.
  • Pacini, Laura
  • Elms, Mark L.
  • Ning, Jian
  • Garcia Martinez, Victor
  • Yu, Yi-Ru
  • Acton, Sophie E.
  • Ho, Ping-Chih
  • Calvo, Fernando
  • Swain, Amanda
  • Howard, Beatrice A.
  • Natrajan, Rachael C.
  • Huang, Paul H.
© 2020. Published by The Company of Biologists Ltd., SWATH-mass spectrometry (MS) enables accurate and reproducible proteomic profiling in multiple model organisms including the mouse. Here, we present a comprehensive mouse reference spectral library (MouseRefSWATH) that permits quantification of up to 10,597 proteins (62.2% of the mouse proteome) by SWATH-MS. We exploit MouseRefSWATH to develop an analytical pipeline for species-specific deconvolution of proteomic alterations in human tumour xenografts (XenoSWATH). This method overcomes the challenge of high sequence similarity between mouse and human proteins, facilitating the study of host microenvironment-tumour interactions from ‘bulk tumour’ measurements. We apply the XenoSWATH pipeline to characterize an intraductal xenograft model of breast ductal carcinoma in situ and uncover complex regulation consistent with stromal reprogramming, where the modulation of cell migration pathways is not restricted to tumour cells but also operates in the mouse stroma upon progression to invasive disease. MouseRefSWATH and XenoSWATH open new opportunities for in-depth and reproducible proteomic assessment to address wide-ranging biological questions involving this important model organism., P.H.H. is supported by grants from the Institute of Cancer Research, Breast Cancer Now (2013NovPhD185 and 2014NovPR360) and Cancer Research UK (C36478/ A19281). B.A.H. and R.C.N. are supported by Breast Cancer Now programmatic funding. S.E.A. is supported by grants from Cancer Research UK (CRUK/A19763) and the Medical Research Council (MC_U12266B). F.C. is supported by grants from the Institute of Cancer Research, the Ramon y Cajal Research Programme (RYC2016-20352) and Ministerio de Ciencia, Innovación y Universidades/Agencia Estatal de Investigación/European Regional Development Fund (RTI2018-096778- A-I00). P.-C.H. is supported in part by a Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung project grant (31003A_182470) and a European Research Council Starting Grant (802773-MitoGuide).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment

  • Araujo, Angela M.
  • Abaurrea, Andrea
  • Azcoaga, Peio
  • López-Velazco, Joanna I.
  • Manzano, Sara
  • Rodríguez, Javier
  • Rezola, Ricardo
  • Egia-Mendikute, Leire
  • Valdés-Mora, Fátima
  • Flores, Juana M.
  • Jenkins, Liam
  • Pulido, Laura
  • Osorio-Querejeta, Iñaki
  • Fernández-Nogueira, Patricia
  • Ferrari, Nicola
  • Viera, Cristina
  • Martín-Martín, Natalia
  • Tzankov, Alexandar
  • Eppenberger-Castori, Serenella
  • Álvarez-López, Isabel
  • Urruticoechea, Ander
  • Bragado, Paloma
  • Coleman, Nicholas
  • Palazón, Asís
  • Carracedo, Arkaitz
  • Gallego-Ortega, David
  • Calvo, Fernando
  • Isacke, Clare M.
  • Caffarel, María M.
  • Lawrie, Charles H.
The tumor microenvironment (TME) is reprogrammed by cancer cells and participates in all stages of tumor progression. The contribution of stromal cells to the reprogramming of the TME is not well understood. Here, we provide evidence of the role of the cytokine oncostatin M (OSM) as central node for multicellular interactions between immune and nonimmune stromal cells and the epithelial cancer cell compartment. OSM receptor (OSMR) deletion in a multistage breast cancer model halted tumor progression. We ascribed causality to the stromal function of the OSM axis by demonstrating reduced tumor burden of syngeneic tumors implanted in mice lacking OSMR. Single-cell and bioinformatic analysis of murine and human breast tumors revealed that OSM expression was restricted to myeloid cells, whereas OSMR was detected predominantly in fibroblasts and, to a lower extent, cancer cells. Myeloid-derived OSM reprogrammed fibroblasts to a more contractile and tumorigenic phenotype and elicited the secretion of VEGF and proinflammatory chemokines CXCL1 and CXCL16, leading to increased myeloid cell recruitment. Collectively, our data support the notion that the stromal OSM/OSMR axis reprograms the immune and nonimmune microenvironment and plays a key role in breast cancer progression., This work was funded by Spanish Ministry of Science and Innovation - ISCIII (PI15/00623, PI18/00458, PI21/01208, CP18/00076, and FI19/00193); European Regional Development (FEDER) funds; Basque Department of Health (2017111011); Fundación SEOM (Beca SEOM-Font Vella); Fundación Gangoiti; and Ikerbasque Basque Research Foundation. The group also received funds from the breast cancer patient’s charity Katxalin and from Roche Farma S.A. AMA and AA are funded by Basque Government Doctoral Training Grants. JILV is funded by an AECC PhD Fellowship. FVM is supported by the Career Development Fellowship from the Cancer Institute New South Wales (2019/CDF002). AP’s research is funded by the European Research Council (ERC, ERC-2018-StG 804236-NEXTGEN-IO), and by the Spanish Ministry of Science and Innovation (PID2019-107956RA-I00 and RYC2018-024183-I). AC’s research is supported by the Basque Department of Industry, Tourism and Trade (Elkartek); the MICINN (PID2019-108787RB-I00 [FEDER/EU]; Excellence Network (SAF2016-81975-REDT); European Training Networks Project (H2020-MSCA-ITN-308 2016 721532); the AECC (GCTRA18006CARR), Vencer el Cáncer Foundation; La Caixa Foundation (ID 100010434), under the agreement LCF/PR/HR17/; and the ERC (Consolidator Grant 819242). CIBERONC was cofunded with FEDER funds and funded by ISCIII. DGO is supported by a Cancer Council NSW project grant (RG18-03) and the National Breast Cancer Foundation Elaine Henry Fellowship (IIRS-21-096). FC is funded by Institute of Cancer Research, Spanish Ministry of Science and Innovation (RYC-2016-20352 and RTI2018-096778-A-I00); Asociacion Española Contra el Cancer (LAB-AECC, LABAE19044CALV); and BBVA Leonardo Awards (IN[19]_BBM_BAS_0076).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Analysis of the role of the histone-deacetylases (HDACs) in the generation of cancer-associated fibroblasts (CAFs)

  • Subijana, María
  • Rodríguez, Javier
  • Calvo, Fernando
Trabajo presentado en el 18th ASEICA International Congress, celebrado en Santiago de Compostela (España) del 16 al 18 de noviembre de 2022., Cancer-associated fibroblasts (CAFs) are the major population within the tumour microenvironment (TME) in many solid carcinomas and generally present tumour-promoting functions, such as promotion of cancer cell growth, survival and invasion, angiogenesis and immunosuppression. Therefore, CAFs can critically regulate tumour initiation, progression and therapeutic response. § CAFs show a pathologically activated phenotype despite the absence of genomic aberrations, suggesting that epigenetic rearrangements might be involved in the emergence of pro-tumorigenic CAFs. § Our aim is to assess whether a dysregulation of the acetylation machinery, in particular of the histone-deacetylases (HDACs), leads to epigenetic rearrangements contributing to distinct CAF phenotypes. § Understanding how HDAC activity is regulated in fibroblasts and its overall effect on CAF emergence may inform of strategies to block the capacity of CAFs to shape aggressive environments. HDAC inhibitors, widely used in cancer therapy, could rise up as a novel approach for targeting tumour stroma., Grant PRE2019-088067 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. Grant PID2021-128107OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. FC lab is funded by AECC (LABAE19044CALV), MCIN/AEI/ 10.13039/501100011033 (RTI2018-096778-A-I00, PID2021-128107OB-I00); AECC (PRYCO211372RODR); BBVA Leonardo Awards (IN[19]_BBM_BAS_0076), and the ERC (ERC-CoG101045756).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Stromal cells regulate mechanics of tumour spheroid

  • Agrawal, Ayushi
  • Lasli, Soufian
  • Javanmardi, Yousef
  • Coursier, Diane
  • Micalet, Auxtine
  • Watson, Sara
  • Shahreza, Somayeh
  • Serwinski, Bianca
  • Djordjevic, Boris
  • Szita, Nicolas
  • Cheema, Umber
  • Bertazzo, Sergio
  • Calvo, Fernando
  • Moeendarbary, Emad
The remarkable contractility and force generation ability exhibited by cancer cells empower them to overcome the resistance and steric hindrance presented by a three-dimensional, interconnected matrix. Cancer cells disseminate by actively remodelling and deforming their extracellular matrix (ECM). The process of tumour growth and its ECM remodelling have been extensively studied, but the effect of the cellular tumour microenvironment (TME) has been ignored in most studies that investigated tumour-cell-mediated ECM deformations and realignment. This study reports the integration of stromal cells in spheroid contractility assays that impacts the ECM remodelling and invasion abilities of cancer spheroids. To investigate this, we developed a novel multilayer in vitro assay that incorporates stromal cells and quantifies the contractile deformations that tumour spheroids exert on the ECM. We observed a negative correlation between the spheroid invasion potential and the levels of collagen deformation. The presence of stromal cells significantly increased cancer cell invasiveness and altered the cancer cells' ability to deform and realign collagen gel, due to upregulation of proinflammatory cytokines. Interestingly, this was observed consistently in both metastatic and non-metastatic cancer cells. Our findings contribute to a better understanding of the vital role played by the cellular TME in regulating the invasive outgrowth of cancer cells and underscore the potential of utilising matrix deformation measurements as a biophysical marker for evaluating invasiveness and informing targeted therapeutic opportunities., AA, EM, and FC are grateful for the financial support by the Cancer Research UK Multidisciplinary Award (C57744/A22057). EM acknowledge financial support by Welcome Trust-MIT Fellowship (WT103883), Leverhulme Trust Research Project Grant (RPG-2018-443), BBSRC (BB/V001418/1). FC was funded by MCIN/AEI/10.13039/501100011033 (RYC-2016-20352, RTI2018-096778-A-I00, PID2021-128107OB-I00); AECC (LABAE19044CALV, PRYCO211372RODR); BBVA Leonardo Awards (IN[19]_BBM_BAS_0076), and the ERC (Consolidator Grant 101045756)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Endothelium and Subendothelial Matrix Mechanics Modulate Cancer Cell Transendothelial Migration

  • Javanmardi, Yousef
  • Agrawal, Ayushi
  • Malandrino, Andrea
  • Lasli, Soufian
  • Chen, Michelle
  • Shahreza, Somayeh
  • Serwinski, Bianca
  • Cammoun, Leila
  • Li, Ran
  • Jorfi, Mehdi
  • Djordjevic, Boris
  • Szita, Nicolás
  • Spill, Fabián
  • Bertazzo, Sergio
  • Sheridan, Graham K.
  • Shenoy, Vivek
  • Calvo, Fernando
  • Kamm, Roger
  • Moeendarbary, Emad
Cancer cell extravasation, a key step in the metastatic cascade, involves cancer cell arrest on the endothelium, transendothelial migration (TEM), followed by the invasion into the subendothelial extracellular matrix (ECM) of distant tissues. While cancer research has mostly focused on the biomechanical interactions between tumor cells (TCs) and ECM, particularly at the primary tumor site, very little is known about the mechanical properties of endothelial cells and the subendothelial ECM and how they contribute to the extravasation process. Here, an integrated experimental and theoretical framework is developed to investigate the mechanical crosstalk between TCs, endothelium and subendothelial ECM during in vitro cancer cell extravasation. It is found that cancer cell actin-rich protrusions generate complex push-pull forces to initiate and drive TEM, while transmigration success also relies on the forces generated by the endothelium. Consequently, mechanical properties of the subendothelial ECM and endothelial actomyosin contractility that mediate the endothelial forces also impact the endothelium's resistance to cancer cell transmigration. These results indicate that mechanical features of distant tissues, including force interactions between the endothelium and the subendothelial ECM, are key determinants of metastatic organotropism., E.M. is grateful for Welcome Trust-MIT Fellowship (WT103883). Y.J. and E.M. acknowledge financial support by Leverhulme Trust Research Project Grant (RPG-2018-443) and the Cancer Research UK Multidisciplinary Award (C57744/A22057). Y.J., E.M., and F.S are grateful for Biotechnology and Biological Sciences Research Council Grant (BB/V001418/1) supports. R.K. and V.S. acknowledge the support from NIH (U54CA261694). F.S. was supported by a UKRI Future Leaders Fellowship, grant number [MR/T043571/1]. F.C. was funded by MCIN/AEI/ 10.13039/501100011033 (RYC-2016-20352, RTI2018-096778-A-I00, PID2021-128107OB-I00); AECC (LABAE19044CALV, PRYCO211372RODR); BBVA Leonardo Awards (IN[19]_BBM_BAS_0076), Cancer Research UK (C57744/A22057) and the ERC (Consolidator Grant 101045756)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance

  • Coursier, Diana
  • Calvo, Fernando
Neoplastic progression involves complex interactions between cancer cells and the surrounding stromal milieu, fostering microenvironments that crucially drive tumor progression and dissemination. Of these stromal constituents, cancer-associated fibroblasts (CAFs) emerge as predominant inhabitants within the tumor microenvironment (TME), actively shaping multiple facets of tumorigenesis, including cancer cell proliferation, invasiveness, and immune evasion. Notably, CAFs also orchestrate the production of pro-angiogenic factors, fueling neovascularization to sustain the metabolic demands of proliferating cancer cells. Moreover, CAFs may also directly or indirectly affect endothelial cell behavior and vascular architecture, which may impact in tumor progression and responses to anti-cancer interventions. Conversely, tumor endothelial cells (TECs) exhibit a corrupted state that has been shown to affect cancer cell growth and inflammation. Both CAFs and TECs are emerging as pivotal regulators of the TME, engaging in multifaceted biological processes that significantly impact cancer progression, dissemination, and therapeutic responses. Yet, the intricate interplay between these stromal components and the orchestrated functions of each cell type remains incompletely elucidated. In this review, we summarize the current understanding of the dynamic interrelationships between CAFs and TECs, discussing the challenges and prospects for leveraging their interactions towards therapeutic advancements in cancer., Spanish Government MCIN/AEI/10.13039/501100011033 (grants RYC-2016‐20352, RTI2018‐096778‐A‐I00, PID2021‐128107OB‐I00); Asociación Española Contra el Cáncer-AECC (grants LABAE19044CALV, PRYCO211372RODR); BBVA Leonardo Awards (grant IN [19]_BBM_BAS_0076), Cancer Research UK (grant C57744/A22057); and the European Research Council-ERC Consolidator Grant antiCAFing (grant ref 101045756). Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature., Peer reviewed